Navigation Links
New IDSAF and NIA Research Grants will Speed Alzheimer’s Microbe Hunt, Says Dr. Leslie Norins of Alzheimer’s Germ Quest, Inc.
Date:6/20/2019

The half-million dollars in Alzheimer’s disease (AD) research grants recently announced by the Infectious Diseases Society of America Foundation, and the possibly millions of dollars of “high priority” grants now offered by the National Institute on Aging to study infectious agents in AD, are a “welcome affirmation” of the need to investigate more thoroughly the possible roles of germs in triggering AD, says Leslie Norins, MD, PhD, CEO of Alzheimer’s Germ Quest, Inc.

“This new funding from these two authorities will help alleviate a severe shortage of research grants to follow up many promising leads that viruses, bacteria and other pathogens are involved in AD,” says Dr. Norins. He urges scientists with microbiological talents to apply.

Strangely, he says, several AD advocacy groups appear to still be ignoring microbes, and continue to channel their research grant monies almost exclusively to the traditional topics of amyloid plaques and tau tangles. Dr. Norins attributes this to a lack of infectious diseases experts on their policy and grant review committees.

Dr. Norins also points to a recent article in ALZFORUM, which reported that an anti-viral medication administered to fight hepatitis C might also reduce the later development of Parkinson’s disease. It said, “[This] supports emerging evidence that infections contribute to neurodegeneration.” Dr. Norins reminds, “AD, like Parkinson’s, is a leading neurodegenerative disease.”

Alzheimer’s Germ Quest is a public benefit corporation, headquartered in Naples. Florida. It is self-funded, and neither solicits nor accepts outside donations. Its mission is to accelerate and deepen research into the possibility that a microbiological agent triggers AD. It is the sponsor of the $1 million Challenge Award for the scientist who proves an infectious organism is the cause of AD. Recently, it launched a $100,000 hunt for the world’s first provable case of spontaneous cure of AD.

Read the full story at https://www.prweb.com/releases/new_idsaf_and_nia_research_grants_will_speed_alzheimers_microbe_hunt_says_dr_leslie_norins_of_alzheimers_germ_quest_inc/prweb16390545.htm.


'/>"/>
Source: PRWeb
Copyright©2019 Vocus, Inc.
All rights reserved


Related biology news :

1. Trivedi Global, Inc. Announces Research by Dahryn Trivedi on the Beneficial Impact of Energy Treated Cefazolin Sodium Antibiotic in Treating Bacterial Infections
2. Research from Ambry Genetics & Mayo Clinic Reveals Differences in the Prevalence of Breast Cancer Genes among Racial and Ethnic Populations
3. Ambry Genetics Research Demonstrates RNA Genetic Testing in Hereditary Cancer Improves Variant Classification and Patient Management
4. ASGCT To Honor Four Ground-Breaking Researchers at 22nd Annual Meeting
5. ACEA Presents xCELLigence Research Grant to Dr. Teresa Krabbe
6. VCU College of Engineering and Fuzionaire Diagnostics to Pursue Joint Research Applying Novel Radiochemistry Platform to Disease Diagnosis and Drug Discovery
7. uBiome Appoints Dr. Julia Oh, PhD, Skin Microbiome Researcher, to its Scientific Advisory Board
8. uBiome Launches Research Collaboration with doc.ai to Potentially Predict Optimal Supplements for Crohn’s Disease
9. Mount Sinai Researchers Use “Blacklist” Computing Concept as Novel Method to Streamline Genetic Analysis
10. Biocompare Releases Documentary on “What Researchers Need to Know about Antibody Manufacturing”
11. ACEA Biosciences Joins Cell Manufacturing Research Initiative to Further Advance Cell Therapy Discovery
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2020)... ... August 20, 2020 , ... NDA Partners Chairman ... Clinical Operations executive with expertise in clinical trial planning and feasibility, regulatory inspection ... Expert Consultant. Throughout his career, Mr. Movahhed has helped design and manage oncology, ...
(Date:8/5/2020)... ... August 05, 2020 , ... Regenative Labs has received approval from the Centers ... making them the first Wharton’s jelly allografts to be assigned a Q code and ... are the first Wharton’s jelly allograft product to be recognized as a 361 HCT/P ...
(Date:7/18/2020)... ... July 16, 2020 , ... A study has ... Invictus Medical Neoasis™ active noise control device to attenuate typical noises in a ... device attenuated the alarm sounds from patient monitors, ventilators and other bedside devices ...
Breaking Biology News(10 mins):
(Date:8/12/2020)... ... August 12, 2020 , ... ... (EMMA International), a global leader in FDA compliance consulting has been named on ... private companies. The list represents a unique look at the most successful companies ...
(Date:7/31/2020)... (PRWEB) , ... July 29, 2020 , ... ... today announced the launch of its new tagline, “BUILDING FOR LIFE.” The adoption ... industry and around the globe, requiring fast track capacity to provide patients with ...
(Date:7/31/2020)... ... July 29, 2020 , ... The SDX® Respiratory ... 16 countries, has reached its 20th anniversary of worldwide use. Introduced in the ... top universities including University of Pennsylvania, University of Michigan, University of Maryland, University ...
(Date:7/18/2020)... ... July 16, 2020 , ... Medial EarlySign , a ... prevention of high-burden diseases, and Centric Consulting, a business and technology consulting firm, ... existing data in order to identify and prioritize patients for care. , Combining ...
Breaking Biology Technology: